Solid Biosciences (SLDB) Share-based Compensation Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 10.78% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.55% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.65% |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - | 34.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.49% |
| Dec 31, 2025 | 60.00% |
| Sep 30, 2025 | 37.11% |
| Jun 30, 2025 | 20.13% |
| Mar 31, 2025 | 8.55% |
| Dec 31, 2024 | 3.82% |
| Sep 30, 2024 | -4.29% |
| Jun 30, 2024 | -16.82% |
| Mar 31, 2024 | -17.86% |
| Dec 31, 2023 | -8.36% |
| Sep 30, 2023 | -16.23% |
| Jun 30, 2023 | -15.68% |
| Mar 31, 2023 | -11.96% |
| Dec 31, 2022 | -22.46% |
| Sep 30, 2022 | -23.41% |
| Jun 30, 2022 | -22.59% |
| Mar 31, 2022 | -9.29% |
| Dec 31, 2021 | 18.93% |
| Sep 30, 2021 | 23.88% |
| Jun 30, 2021 | 40.56% |
| Mar 31, 2021 | 52.54% |
| Dec 31, 2020 | 45.17% |
| Sep 30, 2020 | 51.81% |
| Jun 30, 2020 | 88.14% |
| Mar 31, 2020 | -1.32% |